☆ 4.3 Article

Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics

CONTRACEPTION (2022)

Related references

Note: Only part of the references are listed.

Article Obstetrics & Gynecology

US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care

Silpa Srinivasulu et al.

Summary: FDA regulations restricting the provision of mifepristone in primary care settings create structural barriers, potentially resulting in physical, emotional, and financial burdens for patients.

CONTRACEPTION (2021)

Add to Collection

Article Obstetrics & Gynecology

Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States

Danielle Calloway et al.

Summary: Despite its safety record, mifepristone is subject to a highly restrictive set of regulatory measures through the REMS, reflecting and perpetuating a cycle of abortion stigma. The ExPAND Mifepristone learning collaborative targets institutional anxiety and logistical barriers to increase providers' self-efficacy. Learning collaboratives show promise in addressing the practical and psychological barriers to mifepristone use until the REMS is fully repealed.

CONTRACEPTION (2021)

Add to Collection

Article Obstetrics & Gynecology

The mifepristone REMS: A needless and unlawful barrier to care

Julia Kaye et al.

Summary: Mifepristone, a prescription drug used in the United States for twenty years to end early pregnancies and treat early miscarriages, is subject to strict restrictions by the FDA despite its established safety and efficacy, leading to controversy and legal challenges.

CONTRACEPTION (2021)

Add to Collection

Article Obstetrics & Gynecology

Family medicine provision of online medication abortion in three US states during COVID-19

Emily M. Godfrey et al.

Summary: This study examined the provision of medication abortion by family physicians using an online service called Aid Access in three states in the United States. The results showed that most patients seeking medication abortion were within 7 weeks gestation and had similar reasons for choosing Aid Access regardless of state residence. Family physicians successfully provided medication abortion care through online consultations, increasing geographic access to medication abortion.

CONTRACEPTION (2021)

Add to Collection

Letter Medicine, General & Internal

Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic

Ushma D. Upadhyay et al.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Obstetrics & Gynecology

Trends in medication abortion provision before and after the introduction of mifepristone: A study of the National Abortion Federation's Canadian member services

Abdiasis Yalahow et al.

CONTRACEPTION (2020)

Add to Collection

Article Primary Health Care

Perspectives Among Canadian Physicians on Factors Influencing Implementation of Mifepristone Medical Abortion: A National Qualitative Study

Sarah Munro et al.

ANNALS OF FAMILY MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

How did the introduction of mifepristone impact the availability of abortion care in Ottawa? A qualitative study with abortion patients

Kathryn J. LaRoche et al.

FACETS (2020)

Add to Collection

Article Obstetrics & Gynecology

Intention to provide abortion upon completing family medicine residency and subsequent abortion provision: a 5-year follow-up survey

Silpa Srinivasulu et al.

CONTRACEPTION (2019)

Add to Collection

Review Primary Health Care

Providing Abortion Services in the Primary Care Setting

Jennifer R. Amico et al.

PRIMARY CARE (2018)

Add to Collection

Editorial Material Medicine, General & Internal

Sixteen Years of Overregulation: Time to Unburden Mifeprex

Elizabeth G. Raymond et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Editorial Material Obstetrics & Gynecology

Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data

Kelly Cleland et al.

CONTRACEPTION (2015)

Add to Collection

Article Public, Environmental & Occupational Health

It Is Time to Integrate Abortion Into Primary Care

Susan Yanow

AMERICAN JOURNAL OF PUBLIC HEALTH (2013)

Add to Collection

Article Primary Health Care

Management of Early Pregnancy Failure and Induced Abortion by Family Medicine Educators

Cara Herbitter et al.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2013)

Add to Collection

Article Public, Environmental & Occupational Health

Women's Preferences for the Location of Abortion Services: A Pilot Study in Two Chicago Clinics

Melissa B. Logsdon et al.

MATERNAL AND CHILD HEALTH JOURNAL (2012)

Add to Collection

Article Primary Health Care

Early Abortion in Family Medicine: Clinical Outcomes

Ian M. Bennett et al.

ANNALS OF FAMILY MEDICINE (2009)

Add to Collection

Article Public, Environmental & Occupational Health

Medical liability insurance as a barrier to the provision of abortion services in family medicine

Christine E. Dehlendorf et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2008)

Add to Collection

Article Primary Health Care

Patient attitudes toward early abortion services in the family medicine clinic

Susan E. Rubin et al.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2008)

Add to Collection

Article Public, Environmental & Occupational Health

Three approaches to qualitative content analysis

HF Hsieh et al.

QUALITATIVE HEALTH RESEARCH (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.